Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,400
Closed -$3.52M 1580
2025
Q4
$3.52M Buy
33,400
+27,900
+507% +$2.62M 0.09% 152
2025
Q3
$462K Sell
5,500
-7,300
-57% -$601K 0.01% 658
2025
Q2
$1.01M Buy
+12,800
New +$1.02M 0.02% 296
2024
Q3
Sell
-2,700
Closed -$342K 669
2024
Q2
$342K Buy
2,700
+500
+23% +$64.4K 0.01% 383
2024
Q1
$290K Buy
+2,200
New +$271K 0.01% 284
2022
Q1
Sell
-70,400
Closed -$5.39M 314
2021
Q4
$5.39M Buy
+70,400
New +$5.61M 0.15% 43

Other funds holding MRK

DRW Securities's MRK Position: Q1 2026 in Review

DRW Securities increased its Merck (MRK) stake by 46% in Q1 2026, buying an estimated $170K and bringing the position to 4,666 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #563.

DRW Securities first reported a position in MRK in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.5M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • DRW Securities held 4,666 shares of Merck worth $555K as of Q1 2026.
  • DRW Securities bought 1,472 Merck shares in Q1 2026, an estimated $170K.
  • Merck made up 0.01% of DRW Securities's portfolio in Q1 2026, its #563 holding.
  • DRW Securities first reported a position in Merck in Q2 2013 and has held it in 17 quarters since.
  • DRW Securities's Merck position peaked at $2.5M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.